the second and third prospectively groups consisted of 100 and 200 patients respectively , treated with 1 g ampicillin twice and 1.4 g pivampicillin + probenecid respectively , with re-examinations at intervals of 1 week and 4 weeks after treatment .
C0002680
ampicillin
C0032032
pivampicillin